BEZMIALEM SCIENCE, vol.7, no.4, pp.265-270, 2019 (ESCI)
Objective: Early-stage non-small cell lung cancer (NSCLC) constitutes approximately 25-30% of newly diagnosed lung cancers. Elderly patients with NSCLC have generallly been underrepresented in clinical studies. We explored adjuvant chemotherapy results in patients > 65 years with early-stage NSCLC.